Concerns about Patient Access to Biopharmaceuticals and Outcomes

HKS Affiliated Authors

Ethel Zimmerman Wiener Professor of Public Policy, HKS; Henry and Allison McCance Professor of Business Administration, HBS

Excerpt

January 18, 2023, Paper: "A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices."

In This Section

HKS Affiliated Authors

Excerpt

What Does the Inflation Reduction Act Mean for Patients and Physicians?

Feeling uncertain despite knowing the risk: Patients with OCD (but not controls) experience known and unknown probabilistic decisions as similarly distressing and uncertain

Improving Emergency Department Flow